L, N., & N, X. (2024). SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer. Dove Medical Press.
Chicago Style (17th ed.) CitationL, Ning, and Xie N. SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer. Dove Medical Press, 2024.
MLA (9th ed.) CitationL, Ning, and Xie N. SIRT3 Expression Predicts Overall Survival and Neoadjuvant Chemosensitivity in Triple-Negative Breast Cancer. Dove Medical Press, 2024.
Warning: These citations may not always be 100% accurate.